A Clinical Trial of MK-2010 Alone and With Other Treatments in Participants With Advanced Solid Tumors (MK-2010-002)

Researchers are looking for new ways to treat certain types of advanced solid tumors.Solid tumors are cancers mostly in organs and tissues in the body, not in the blood orother fluids. Advanced means the cancer has spread nearby or to other parts in the bodyand cannot be removed with surgery.In this trial, researchers want to learn if the trial medicine called MK‐2010, givenalone or with other treatments, can treat advanced solid tumors. MK‐2010 is designed tohelp the immune system fight cancer.The goals of this trial are to learn: ‐ About the safety of MK‐2010 as monotherapy and in combinations and if participantstolerate them. Tolerate means participants will receive trial treatment unless theyneed to stop it due to health problems. ‐ How many participants who receive MK‐2010 as monotherapy and in combination respondto treatment. Respond means the cancer gets smaller or goes away.